<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>The 2008 World Health Organization (WHO) proposed revision of the classification of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> recognizes a deletion (5q) subtype with mutation of Janus kinase-2 (JAK2(V617F)) </plain></SENT>
<SENT sid="1" pm="."><plain>We investigated the clonal origin of this gene mutation in a patient with del(5q) <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> presenting with <z:hpo ids='HP_0001894'>thrombocytosis</z:hpo> and <z:mpath ids='MPATH_458'>normal</z:mpath> <z:chebi fb="0" ids="35143">hemoglobin</z:chebi> </plain></SENT>
<SENT sid="2" pm="."><plain>Analysis of colony forming units-granulocyte-monocyte (CFU-GM) and erythropoietin-independent growth of bone marrow (BM) and peripheral blood (PB) burst forming units-erythroid (BFU-E) showed that del(5q) and JAK2(V617F) existed in progenitors derived from independent clones </plain></SENT>
<SENT sid="3" pm="."><plain>Fifty percent of endogenous erythroid colonies (EEC) harbored the JAK2(V617F) mutation whereas fluorescent in situ hybridization (Fish) with a chromosome 5 (q31.1) probe showed only a diploid allele compliment </plain></SENT>
<SENT sid="4" pm="."><plain>Assessment of transcriptional clonality by <z:chebi fb="0" ids="33820">iduronate</z:chebi>-2-sulfatase (IDS) gene polymorphism suggested that JAK2(V617F) was acquired in at least two independent multipotent stem cell progeny </plain></SENT>
<SENT sid="5" pm="."><plain>Our findings indicate that JAK2(V617F) mutant clones may arise in genetically discordant clones independent of del(5q) </plain></SENT>
</text></document>